Jean-Michel Boers

Chief Executive Officer at Boehringer Ingelheim Pharmaceuticals, Inc.

Health Technology

Consumer Services

Profile

Jean-Michel Boers is currently the President & Chief Executive Officer at Boehringer Ingelheim Pharmaceuticals, Inc. He previously served as the Chairman & Chief Executive Officer at Boehringer Ingelheim France SASU.
He holds an MBA from The University of Texas at Austin and a graduate degree from Radboud University Nijmegen.

Jean-Michel Boers active positions

Companies	Position	Start
Boehringer Ingelheim Pharmaceuticals, Inc. Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Pharmaceuticals, Inc. manufactures pharmaceuticals products. It develops and markets drugs for the treatment of respiratory, cancer, cardiovascular, immunological and central nervous system diseases. The company was founded in 1971 and is headquartered in Ridgefield, CT.	Chief Executive Officer	31/07/2020

All active positions of Jean-Michel Boers

Former positions of Jean-Michel Boers

Companies	Position	End
Boehringer Ingelheim France SASU Boehringer Ingelheim France SASU Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim France SAS engages in the research, development, marketing, and distribution of pharmaceuticals. The company was founded on October 31, 1986 and is headquartered in Paris, France.	Chief Executive Officer	-

See the detail of Jean-Michel Boers's experience

Training of Jean-Michel Boers

Radboud University Nijmegen	Graduate Degree
The University of Texas at Austin	Masters Business Admin

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Jean-Michel Boers's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	2
Boehringer Ingelheim France SASU Boehringer Ingelheim France SASU Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim France SAS engages in the research, development, marketing, and distribution of pharmaceuticals. The company was founded on October 31, 1986 and is headquartered in Paris, France.	Health Technology
Boehringer Ingelheim Pharmaceuticals, Inc. Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Pharmaceuticals, Inc. manufactures pharmaceuticals products. It develops and markets drugs for the treatment of respiratory, cancer, cardiovascular, immunological and central nervous system diseases. The company was founded in 1971 and is headquartered in Ridgefield, CT.	Health Technology